A big breakthrough in the fight against Coronavirus has come to the fore as researchers at the University of Oxford have claimed that a steroid called dexamethasone could be beneficial for critical COVID-19 patients.
The results of the UK-based ‘RECOVERY’ trial published on Tuesday described the drug as highly-effective on reducing mortality rate, especially on those patients on ventilator for respiratory complications.
The researchers concluded the life saving property after the drug was the widely available drug was administered to more than 2,000 severely ill COVID-19 patients, a AFP report said.
According to preliminary results, the drug reduced death by 35 pecent of those who could only breathe with the help of a ventilator while it reduced deaths of those receiving oxygen by a fifth.
“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” Peter Horby, professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, University of Oxford, was quoted as saying by the report. “Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.”